Th9 cells promote antitumor immune responses in vivo
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Th9 cells are a subset of CD4+ Th cells that produce the pleiotropic cytokine IL-9. IL-9/Th9 can function as both positive and negative regulators of immune response, but the role of IL-9/Th9 in tumor immunity is unknown. We examined the role of IL-9/Th9 in a model of pulmonary melanoma in mice. Lack of IL-9 enhanced tumor growth, while tumor-specific Th9 cell treatment promoted stronger antitumor responses in both prophylactic and therapeutic models. Th9 cells also elicited strong host antitumor CD8+ CTL responses by promoting Ccl20/Ccr6-dependent recruitment of DCs to the tumor tissues. Subsequent tumor antigen delivery to the draining LN resulted in CD8+ T cell priming. In agreement with this model, Ccr6 deficiency abrogated the Th9 cell-mediated antitumor response. Our data suggest a distinct role for tumor-specific Th9 cells in provoking CD8+ CTL-mediated antitumor immunity and indicate that Th9 cell-based cancer immunotherapy may be a promising therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-9 has been shown to favour CD8 T-cell activation in a model of pulmonary melanoma in mice36.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“This observation is in contrast to previous findings demonstrating a role of Th9 cells in controlling anti-tumour immune responses in solid tumours such as melanomas.26,27”
From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., & Stockinger, B. (2008) · Nature Immunology · doi:10.1038/ni.1659 · Cited by 1,213
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122
Maldonado-López, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J., & Moser, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.587 · Cited by 984
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
Self-citationT Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800
Helping the CD8+ T-cell response
Bevan, M. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1413 · Cited by 797
Cited by
Items 201–300 of 382
Spear, T. T., Wang, Y., Smith, T. W., Simms, P. E., Garrett-Mayer, E. S., Hellman, L. M., Baker, B. M., & Nishimura, M. I. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.01.015 · Cited by 15
Khokhar, M., Purohit, P., Gadwal, A., Tomo, S., Bajpai, N. K., & Shukla, R. K. G. (2023) · JMIR Bioinformatics and Biotechnology · doi:10.2196/42421 · Cited by 16
Gressler, A. E., Leng, H., Zinecker, H., & Simon, A. K. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101838 · Cited by 18
Lee, W. H., Hong, K. J., Li, H., & Lee, G. R. (2023) · Advanced Science · doi:10.1002/advs.202305527 · Cited by 17
Self-citationMemon, M. A., Naqvi, M. A., Xin, H., Meng, L., Hasan, M. W., Haseeb, M., Lakho, S. A., Aimulajiang, K., Bu, Y., Xu, L., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008218 · Cited by 25
Zhou, Q., Zhang, H., Wang, Z., Zeng, H., Liu, Z., Huang, Q., Lin, Z., Qu, Y., Xiong, Y., Wang, J., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33237 · Cited by 15
Self-citationHarnessing TH9 cells in cancer immunotherapy
Benoit-Lizon, I., & Apétoh, L. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101477 · Cited by 15
Unveil the mysterious mask of cytokine-based immunotherapy for melanoma
Xu, D. H., Zhu, Z., Xiao, H., Wakefield, M. R., Bai, Q., Nicholl, M. B., Ding, V. A., & Fang, Y. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.022 · Cited by 15
Lipid nanoparticles for engineering next generation CAR T cell immunotherapy
Ang, M. J. Y., Metzloff, A. E., Thatte, A. S., & Mitchell, M. J. (2026) · Nanoscale Horizons · doi:10.1039/d5nh00432b · Cited by 20
Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy
Xiao, S. J., Duan, S., Ya-qun, H., Zhang, J., Ma, S., Caligiuri, M. A., & Yu, J. (2025) · Nature Immunology · doi:10.1038/s41590-025-02235-2 · Cited by 16
Mangus, C. W., Massey, P. R., Fowler, D. H., & Amarnath, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072305 · Cited by 14
Liudahl, S. M., & Coussens, L. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809819-6.00008-3 · Cited by 14
Canaria, D. A., Clare, M. G., Yan, B., Campbell, C. B., Ismaio, Z. A., Anderson, N. L., Park, S., Dent, A. L., Kazemian, M., & Olson, M. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1032618 · Cited by 16
The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy
Vinokurova, D., & Apétoh, L. (2023) · Biomolecules · doi:10.3390/biom13040670 · Cited by 14
The Dichotomy of Interleukin-9 Function in the Tumor Microenvironment
Cannon, A., Pajulas, A., Kaplan, M. H., & Zhang, J. (2023) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2023.0035 · Cited by 14
Decreased frequency of circulating Th9 cells in patients with chronic hepatitis B infection
Cui, M., Lv, Y., Lu, J., Zhang, W., Duan, Y., Huang, Y., Yang, L., Li, M., Liu, W., Liu, D., et al. (2017) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22246 · Cited by 14
Zhang, J., Lian, M., Li, B., Gao, L., Tanaka, T., You, Z., Wei, Y., Chen, Y., Li, Y., Li, Y., et al. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08803-8 · Cited by 15
Cheng, X., Ma, F.-P., Yan, Y., Zhao, W., Shi, J., Xiao, W. L., Bi, E., & Luo, Q. (2022) · Organic Letters · doi:10.1021/acs.orglett.2c02978 · Cited by 14
Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc)
Klein, M., Schmalzing, M., Almanzar, G., Benoit, S., Hamm, H., Tony, H., Goebeler, M., & Prelog, M. (2016) · Autoimmunity · doi:10.1080/08916934.2016.1217997 · Cited by 15
Benhamouda, N., Besbes, A., Bauer, R., Mabrouk, N., Gadouas, G., Desaint, C., Chevrier, L., Lefebvre, M., Radenne, A., Roelens, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110441 · Cited by 14
Targeting γc family cytokines with biologics: current status and future prospects
Bick, F., Blanchetot, C., Lambrecht, B. N., & Schuijs, M. J. (2025) · mAbs · doi:10.1080/19420862.2025.2468312 · Cited by 15
Chen, T., Xue, Y., Wang, S., Lu, J., Zhou, H., Zhang, W., Zhou, Z., Li, B., Li, Y., Wang, Z., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.11.022 · Cited by 16
Lu, Y., Lin, H., Zhai, K., Wang, X., Zhou, Q., & Shi, H. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0097-y · Cited by 13
Self-citationNiu, A., Zou, J., Hu, X., Zhang, Z., Su, L., Wang, J., Xing, L., Zhang, W., Chen, W., & Zhang, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1068625 · Cited by 14
Pan, H., Tian, Y., Pei, S., Yang, W., Zhang, Y., Gu, Z., Zhu, H., Zou, N., Zhang, J., Jiang, L., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00520-8 · Cited by 12
Induction of specific T helper-9 cells to inhibit glioma cell growth
Zheng, H., Yang, B., Xu, D., Wang, W., Tan, J., Sun, L., Li, Q., Sun, L., & Xia, X. (2016) · Oncotarget · doi:10.18632/oncotarget.13981 · Cited by 12
Immune‐mediated antitumor effect of a transplanted lymph node
Maeda, T., Hayashi, T., Furukawa, H., Iwasaki, D., Ishikawa, K., Funayama, E., Murao, N., Osawa, M., Oyama, A., & Yamamoto, Y. (2018) · International Journal of Cancer · doi:10.1002/ijc.31414 · Cited by 14
Role of type 2 innate lymphoid cell and its related cytokines in tumor immunity
Wan, J., Cai, W., Wang, H., Cheng, J., Su, Z., Wang, S., & Xu, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29287 · Cited by 11
IL-24 is the key effector of Th9 cell-mediated tumor immunotherapy
Chen, J., Zhang, Y., Zhang, H., Zhang, M., Dong, H., Qin, T., Gao, S., & Wang, S. (2023) · iScience · doi:10.1016/j.isci.2023.107531 · Cited by 11
Dectin-1 stimulates IL-33 expression in dendritic cells via upregulation of IRF4
Wang, D., Gao, S., Chen, J., Zhao, Y., Jiang, Y., Chu, X., Wang, X., Liu, N., Qin, T., Yi, Q., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0047-2 · Cited by 11
Self-citation(2017) · PubMed Central · Cited by 11
TNF-a Is a Potent Stimulator of Tc9-Cell Differentiation
Yang, S., Chen, J., Zhang, H., Jiang, Y., Qin, T., Gao, S., Yue, Y., & Wang, S. (2020) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000335 · Cited by 11
Huang, M., & Dong, J. (2021) · Journal of Immunology Research · doi:10.1155/2021/8816055 · Cited by 12
Cai, M., & Chen, N. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.817069 · Cited by 16
West, E. J., Scott, K. J., Tidswell, E. L., Bendjama, K., Stojkowitz, N., Lusky, M., Kurzawa, M., Prasad, R. K., Toogood, G. J., Ralph, C., et al. (2022) · Cancers · doi:10.3390/cancers14092181 · Cited by 11
Tang, Z., Shen, Q., Xie, H., Zhou, Z., Shi, G., Zhang, C., Mohammed, A., Wu, Y. Z., Ni, S., & Zhou, X. (2018) · Oncology Reports · doi:10.3892/or.2018.6181 · Cited by 17
The Roles of CD4+ T-Cells in Tumor Immunity
Tavakolpour, S., & Darvishi, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_5 · Cited by 12
GITR drives TH9-mediated antitumor immunity
Kim, I., Chung, Y., & Kang, C. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1122862 · Cited by 10
CCR6–CCL20-Mediated Immunologic Pathways in Inflammatory Bowel Disease
Ranasinghe, R., & Eri, R. D. (2018) · Gastrointestinal Disorders · doi:10.3390/gidisord1010003 · Cited by 10
The dichotomous function of interleukin-9 in cancer diseases
Gerlach, K., & Weigmann, B. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01826-5 · Cited by 10
Végran, F., Martin, F., Apétoh, L., & Ghiringhelli, F. (2016) · médecine/sciences · doi:10.1051/medsci/20163204017 · Cited by 10
Functional diversity and regulation of IL-9-producing T cells in cancer immunotherapy
Kalim, M., Jing, R., Guo, W., Xing, H., & Lu, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217306 · Cited by 11
Self-citationEmerging Role and Function of Th9 Cells in Allergic Inflammation
Kaminuma, O., Kitamura, N., & Gotoh, M. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s546234 · Cited by 11
Wu, X., Zhou, Q., Lin, H., Zhai, K., Wang, X., Yang, W.-B., & Shi, H. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0396oc · Cited by 9
Exogenous IL-9 Ameliorates Experimental Autoimmune Myasthenia Gravis Symptoms in Rats
Yao, X., Zhao, J., Kong, Q., Xie, X., Wang, J., Sun, B., Xu, L., Mu, L., & Li, H. (2018) · Immunological Investigations · doi:10.1080/08820139.2018.1487976 · Cited by 9
Self-citationPang, N., Xu, J., Qu, J., Duan, X., Yuan, H., Chen, G., Jiang, M. Y., & Ding, J. (2017) · PubMed Central · Cited by 11
Self-citationRoy, S., Goel, R., Aggarwal, S., Asthana, S., Yadav, A. K., & Awasthi, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-67845-2 · Cited by 9
GITRL enhances cytotoxicity and persistence of CAR-T cells in cancer therapy
Tan, B., Tu, C., Xiong, H., Xu, Y., Shi, X., Zhang, X., Yang, R., Zhang, N., Lin, B., Liu, M., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.036 · Cited by 8
Th9-derived IL-9 in autoimmune diseases: An update
Chen, W., Xu, Z., Xu, H., Ho, S., Yu, C., He, R., Tam, L., Wei, W., & Tu, J. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123720 · Cited by 8
T Cell Receptor and Co-Stimulatory Signals for Th9 Generation
Meylan, F., & Gómez‐Rodríguez, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6877-0_5 · Cited by 8
Reisser, T., Halbgebauer, D., Scheurer, J., Wolf, L., Leithäuser, F., Beyersdorf, N., Fischer‐Posovszky, P., Debatin, K., & Strauß, G. (2020) · Leukemia · doi:10.1038/s41375-020-0731-2 · Cited by 8
Th9 Cells: New Member of T Helper Cell Family
Goswami, R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6877-0_1 · Cited by 10
Irradiated whole‑cell vaccine suppresses hepatocellular carcinoma growth in mice via Th9 cells
Chen, J., Ding, Y., Huang, F., Lan, R., Wang, Z., Huang, W., Chen, R., Wu, B., Fu, L., Yang, Y., et al. (2021) · Oncology Letters · doi:10.3892/ol.2021.12670 · Cited by 9
Deciphering CD4+ T cell‐mediated responses against cancer
Kirkpatrick, C. A., & Lu, Y. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23730 · Cited by 8
Self-citationNatural lung-tropic TH9 cells: a sharp weapon for established lung metastases
Chen, T., Qiao, C., Yinwang, E., Wang, S., Wen, X., Feng, Y., Jin, X., Li, S.-M., Xue, Y., Zhou, H., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009629 · Cited by 7
Self-citationFunctions of Group 2 Innate Lymphoid Cells in Tumor Microenvironment
Xiong, J., Wang, H., He, J., & Wang, Q. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01615 · Cited by 7
Self-citationProgression or suppression: Two sides of the innate lymphoid cells in cancer
Hosseini, S. H., Sharafkandi, N., Seyfizadeh, N., Hemmatzadeh, M., Marofi, F., Shomali, N., Karimi, M., & Mohammadi, H. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29503 · Cited by 7
Targeting B-cell malignancies through human B-cell receptor specific CD4 + T cells
Weng, J., Baio, F. E., Moriarty, K. E., Torikai, H., Wang, H., Liu, Z., Maiti, S. N., Gwak, D., Popescu, M. S., Cha, S.-C., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1232220 · Cited by 7
Self-citationRegulatory mechanisms of Th9 cell differentiation
Liu, X., Li, Y., Wu, W., Huang, H., Hao, Y., & Song, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1650972 · Cited by 9
T helper-9 cells and Interleukin-9 in transplantation: The open question
Assadiasl, S., Fatahi, Y., & Nicknam, M. H. (2022) · Human Immunology · doi:10.1016/j.humimm.2022.03.006 · Cited by 9
Role of Lymphocytes in Cancer Immunity and Immune Evasion Mechanisms
Kushekhar, K., Chellappa, S., Aandahl, E. M., & Taskén, K. (2022) · Springer eBooks · doi:10.1007/978-3-030-98950-7_10 · Cited by 7
Physical attraction of Th9 cells is skin deep.
Dardalhon, V., Collins, M. A., & Kuchroo, V. K. (2015) · PubMed Central · doi:10.3978/j.issn.2305-5839.2015.01.28 · Cited by 8
Gouyou, B., Ongaro, T., Cazzamalli, S., Luca, R. D., Kerschenmeyer, A., Valet, P., Villa, A., Neri, D., & Matasci, M. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370220981578 · Cited by 7
Role and recruitment of Th9 cells in liver cirrhosis patients
Qin, S., Wang, J.-X., Chen, M., Yang, X., & Jiang, H.-X. (2016) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2015.11.010 · Cited by 5
Flow Cytometric Assessment of STAT Molecules in Th9 Cells
Garo, L. P., Beynon, V., & Murugaiyan, G. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6877-0_10 · Cited by 5
Interleukin-33: Friend or Enemy in the Fight against Tumors?
Gorbacheva, A. M., & Mitkin, N. A. (2019) · Molecular Biology · doi:10.1134/s0026893319050066 · Cited by 5
Turner, M. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_15 · Cited by 7
IL-9: a new culprit in atherosclerosis?
Taleb, S., & Tedgui, A. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv134 · Cited by 5
Park, J. H., Lee, D. U., Jeong, J., Jung, K. H., & Hong, S. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.017 · Cited by 4
Self-citationLaresgoiti‐Servitje, E. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000361 · Cited by 4
Jang, Y. W., Gil, K. C., Lee, J. S., Kang, W., Park, S., & Hwang, K. W. (2019) · Bioelectromagnetics · doi:10.1002/bem.22219 · Cited by 4
[Expression of interleukin-9 in colon cancer tissues and its clinical significance].
Wang, J., Dong, X., Zhu, X., Zhao, H., Mao, D., & Zhao, X. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.08.07 · Cited by 5
TH9 cells and interleukin-9 in parasitic infections: Updates, opportunities, and challenges
Orozco-Cordoba, J., Marcial-Medina, C., & Licona-Limón, P. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.102003 · Cited by 3
Ozkan, E. M., Karadağ, İ., Sahın, E., Cengiz, A. N., Cengiz, M., Güven, D. C., Bozkurt, O., Inanc, M. P., Özkan, M., Kefeli, U., et al. (2026) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2026.2615853 · Cited by 3
Интерлейкин-33: друг или враг в борьбе против опухоли?
Gorbacheva, A. M., & Mitkin, N. A. (2019) · Molecular Biology · doi:10.1134/s0026898419050069 · Cited by 5
Ceylan, A., Artaç, M., Koçak, M. Z., & Artaç, H. (2024) · Scandinavian Journal of Immunology · doi:10.1111/sji.13398 · Cited by 3
Less cholesterol means better tumor killing for cytotoxic T9 cells
Griesenauer, B., & Paczesny, S. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180852 · Cited by 3
He, X.-M., Cui, Y.-Q., He, D.-L., Zhao, J.-X., Zhao, L., & Huang, G. (2022) · Research Square · doi:10.21203/rs.3.rs-2012413/v1 · Cited by 3
Vos, T. D., Godar, M., Bick, F., Papageorgiou, A. C., Evangelidis, T., Marković, I., Mortier, E., Dumoutier, L., Tripsianes, K., Blanchetot, C., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.30.522308 · Cited by 3
JAKing up IL-9 expression in TH9 cells
Muñoz-Paleta, O., & Licona-Limón, P. (2023) · Nature Immunology · doi:10.1038/s41590-023-01509-x · Cited by 3
Immunotherapy for Cutaneous Melanoma
Soleymanitabar, A., Keshavarz‐Fathi, M., Hargadon, K. M., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_237-1 · Cited by 2
Xu, J., & Apétoh, L. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-011522 · Cited by 3
Self-citationDevelopment of therapeutic cancer vaccines based on cancer immunity cycle
Zhang, J., Zheng, Y., Xu, L., Gao, J., Ou, Z., Zhu, M., & Wang, W. (2025) · Frontiers of Medicine · doi:10.1007/s11684-025-1134-6 · Cited by 2
Self-citationZhao, W., Zhou, Y., Chen, Y., Sun, Y., Tang, J., Zhu, Y., Ren, J., Du, T., Wang, H., Gao, Y., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci196907 · Cited by 2
Islam, R., Figura, M., Heyer, J., Lieber, S., Huber, M., Loveland, K. L., Schuppe, H., & Fietz, D. (2026) · Andrology · doi:10.1111/andr.70200 · Cited by 4
First Characterization of Chicken Interleukin-9
He, S., Chen, L., Hao, X., Yang, Y., & Shang, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889991 · Cited by 3
Lin, T.-W., Chou, P.-Y., Shen, Y.-T., Sheu, M., Chuang, K., Lin, S., & Chang, C.-Y. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s476715 · Cited by 2
Wang, J., Xie, H., Gong, Y., Liu, S., Guan, Y.-T., Zhang, Y., Xie, Q., Wang, J., Li, Y., Zeng, X., et al. (2026) · MedComm · doi:10.1002/mco2.70721 · Cited by 2
B16 Lung Melanoma Model to Study the Role of Th9 Cells in Cancer
Dwivedi, A., Kumar, S., & Purwar, R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6877-0_17 · Cited by 2
Interaction between Th9 cells, Interleukin-9 and Oxidative Stress in Chronic Lymphocytic Leukemia
Sabry, S. A., El‐Senduny, F. F., Abousamra, N. K., El-Din, M. S., Esmael, M., & Youssef, M. M. (2019) · Trends in Applied Sciences Research · doi:10.3923/tasr.2019.56.69 · Cited by 2
Taso, E., Rakić, M., Stefanović, V., Petković-Ćurčin, A., Stanojević, I., Djukic, M. M., Struillou, X., Vojvodić, D., Banovic, T., & Kanjevac, T. (2019) · Serbian Journal of Experimental and Clinical Research · doi:10.2478/sjecr-2019-0015 · Cited by 2
Critical role of m6A modification in T-helper cell disorders
Chen, X., Tong, X., Zhou, L., Huang, J. J., Gao, L., Zeng, J., & Tan, L. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.08.015 · Cited by 3
Diken, M., Boegel, S., Grunwitz, C. R., Kranz, L. M., Reuter, K. C., van de Roemer, N., Vascotto, F., Vormehr, M., & Kreiter, S. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29767 · Cited by 1
Interleukin-33: A new frontier in cancer immunotherapy
Kaur, A., Bittorf, K. J., Chanda, A., Kinzel, M., Seo, H., Yu, H., Huang, Q., Belz, G. T., Bose, P., & Jacquelot, N. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.03.002 · Cited by 1
Shahreen, N., Agnihotri, A., Rizwan, A., Hasan, F., Ansari, M. D., Sofian, Z. M., Said, N. A. B. M., To, K. K. W., & Mahmood, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1643791 · Cited by 1
Macrophage-intrinsic and IL-9–dependent arginine metabolism promotes lung tumor growth
Cannon, A., Zhang, J., Ropa, J. P., Pajulas, A., Cheung, C. C. L., Niese, M., Abdelaal, A. M., Khan, S., Bromley, E. K., Hwang, G., et al. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag026 · Cited by 1
Emerging role of RNA modification reader YTHDF2 in hematopoiesis, immunity, and cancer
Liu, X., Xiao, S., Duan, S., Chen, J., & Ma, S. (2026) · MedScience · doi:10.1007/s11684-026-1203-5 · Cited by 2
Novel therapeutic strategies leveraging TH9 cell anticancer functions
Xu, J., Abdoul‐Azize, S., & Apétoh, L. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102026 · Cited by 1
Self-citationAfrough, N., Soltani, A., Khosravi, M., Yadollahi, N., Khodadadi, A., & Shohan, M. (2026) · Inflammation and Regeneration · doi:10.1186/s41232-026-00423-7 · Cited by 1
The role of T helper 9 cells and interleukin-9 in allergic diseases
Yu, C., Xue, Z., He, R., Wu, H., & Tu, J. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124547 · Cited by 1
Metadata
- Authors
- Lu, Y., Hong, S., Li, H., Park, J., Hong, B., Wang, L., Zheng, Y., Liu, Z., Xu, J., He, J., Yang, J., Qian, J., & Yi, Q.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Yi, Qing
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-15
- Volume
- 122
- Issue
- 11
- Pages
- 4160-4171
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3484462
- OpenAlex
- W2066906123
- Cited by
- 361
- References
- 50
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 19 · 2023: 25 · 2022: 27 · 2021: 24 · 2020: 33 · 2019: 37 · 2018: 35 · 2017: 34 · 2016: 34 · 2015: 26 · 2014: 18 · 2013: 13 · 2012: 1
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Multiple Myeloma Research Foundation
- Commonwealth Foundation
- Leukemia and Lymphoma Society
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (R01CA138402, R01CA138398, R01CA163881, P50CA142509, P30CA016672)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Th9 cells, IL-9, antitumor immunity, pulmonary melanoma, CD8+ cytotoxic T lymphocytes, dendritic cell recruitment, tumor antigen delivery, draining lymph nodes, cancer immunotherapy, CD4+ T cells
- MeSH terms
- Animals, Dendritic Cells, T-Lymphocytes, Helper-Inducer, Immunity, Cellular, Immunotherapy, Lung Neoplasms, Melanoma, Interleukin-9, Antigen Presentation, Mice, Knockout, CD8-Positive T-Lymphocytes, Cell Line, Tumor, Mice, Receptors, CCR6, Chemokine CCL20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.